Dr. Baskin-Bey is a physician scientist and an international oncology biopharmaceutical veteran with more than 25 years’ experience in academia and industry. She is the Founder and President of the EGCC, an international boutique oncology consulting firm, which provides multifunctional clinical development support to life science companies. She also serves as an oncology IRB member.

Previously, she has held multiple oncology board of director positions and advisory roles with biotech, life science investment firms, clinical research, and nonprofit organizations. She has also successfully ushered multiple regional regulatory meetings and led the drug launch and life cycle management of several large global oncology programs as the Head of European Oncology Medical Affairs at the Oncology Business Unit for Astellas Pharma.

Dr. Baskin-Bey received a bachelor’s degree in chemistry from Hunter College, a medical degree from Mount Sinai/NYU School of Medicine, general surgery and oncology training at the Mayo Clinic, clinical trial biostatistics training from EORTC, and business leadership training from INSEAD.  

Back to Advisory Committee